Hemab Therapeutics Holdings, Inc. (COAG) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| FCF Yield | -5.2% |
| Sector P/E (Healthcare) | 21.6 |
COAG overview · COAG earnings · COAG KPIs · COAG investor relations · COAG ownership · COAG peers · COAG filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.